What to Expect:
Analysts are projecting Humana to come in with earnings of $1.53 per share, 1.3% less than a year ago when it reported earnings of $1.55 per share. The consensus estimate is down from three months ago when it was $1.90, but is unchanged over the past month. Analysts are projecting earnings of $8 per share for the fiscal year. Revenue is expected to be $10.09 billion for the quarter, 9.8% higher than the year-earlier total of $9.19 billion. For the year, revenue is projected to come in at $39.37 billion.
Trends to Watch For:
The company has posted increasing profit for three quarters in a row. The 85.2% year-over-year growth in net income in the most recent quarter came after the 13.1% profit growth in the third quarter of the last fiscal year and the 35.3% rise in the second quarter of the last fiscal year.
Analyst Ratings:
The majority of analysts (60%) rate Humana as a buy. This compares favorably to the analyst ratings of its nearest 10 competitors, which average 46.8% buys. Analyst sentiment has waned during the last three months.
Competitors:
Humana is a benefits solutions company that offers an array of health and supplemental benefit products for employer groups, government benefit programs and individuals. One of Humana’s main competitors in the healthcare providers and services industry is UnitedHealth Group (UNH). Other competitors in the healthcare sector include: WellPoint (WLP), Aetna (AET), and Molina Healthcare (MOH).
Recent Price Movement:
The stock price has risen from $86.86 on January 26, 2012 to $88.84 over the past quarter.
Earnings estimates provided by Zacks.
For the latest updates on the stock market, PRESS CTR + D or visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today
No comments:
Post a Comment